State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou 310003, China.
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou 310003, China.
Int J Infect Dis. 2017 Jun;59:131-136. doi: 10.1016/j.ijid.2017.04.002. Epub 2017 Apr 10.
Hepatitis B virus (HBV) infection is associated with an increased risk of hepatic cirrhosis, hepatocellular carcinoma, fulminant hepatitis and end-stage hepatic failure. Despite the availability of anti-HBV therapies, HBV infection remains a major global public health problem. Developing an ideal animal model of HBV infection to clarify the details of the HBV replication process, the viral life cycle, the resulting immunoresponse and the precise pathogenesis of HBV is difficult because HBV has an extremely narrow host range and almost exclusively infects humans. In this review, we summarize and evaluate animal models available for studying HBV infection, especially focusing on humanized chimeric mouse models, and we discuss future development trends regarding immunocompetent humanized mouse models that can delineate the natural history and immunopathophysiology of HBV infection.
乙型肝炎病毒 (HBV) 感染与肝肝硬化、肝细胞癌、暴发性肝炎和终末期肝功能衰竭的风险增加有关。尽管有抗 HBV 治疗方法,但 HBV 感染仍然是一个重大的全球公共卫生问题。开发理想的 HBV 感染动物模型以阐明 HBV 复制过程、病毒生命周期、由此产生的免疫反应以及 HBV 的精确发病机制具有挑战性,因为 HBV 的宿主范围极其狭窄,几乎只感染人类。在这篇综述中,我们总结和评估了可用于研究 HBV 感染的动物模型,特别是关注人源化嵌合小鼠模型,并讨论了可描绘 HBV 感染自然史和免疫病理生理学的免疫活性人源化小鼠模型的未来发展趋势。